07:13 AM EST, 11/03/2025 (MT Newswires) -- Krystal Biotech ( KRYS ) reported Q3 earnings Monday of $2.66 per diluted share, up from $0.91 a year earlier.
Two analysts polled by FactSet expected $0.95.
Net product revenue for the quarter ended Sept. 30 was $97.8 million, compared with $83.8 million a year earlier.
Analysts surveyed by FactSet expected $93.2 million.